NTRK1 and cancer: Nerve growth factor (NGF), released by cancer cells and associated stromal cells, is thought to be a key player in the nerve sprouting as therapies that block the NGF/tropomyosin receptor kinase A (TrkA) pathway in early stages block the sprouting and effectively attenuate the development of cancer-induced bone pain (6, 19).